Prognostic value of miR-29a expression in pediatric acute myeloid leukemia

Clinical Biochemistry

Volumn 46, Issue 1-2, 2013, Pages 49-53

  Zhu, Conglong ^a   Wang, Yeguo ^b   Kuai, Wenxia ^a   Sun, Xingzhen ^a   Chen, Huaiping ^a   Hong, Ze ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Huai'an Maternal and Child Health Care Center   (China)

Author keywords

MicroRNA 29a; Pediatric acute myeloid leukemia; Prognosis; Real time quantitative PCR

Indexed keywords

ANTINEOPLASTIC AGENT; BEHENOYL 1 H D ARABINOFURANOSYLCYTOSINE; MICRORNA 29A; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INDUCTION CHEMOTHERAPY; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TREATMENT RESPONSE;

BONE MARROW CELLS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84871735114     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.09.002     Document Type: Article

References (24)

1. Stirewalt D.L., Meshinchi S. Receptor tyrosine kinase alterations in AML - biology and therapy. Cancer Treat Res 2009, 145:85-108.
2. Park M.H., Cho S.A., Yoo K.H., Yang M.H., Ahn J.Y., Lee H.S., et al. Gene expression profile related to prognosis of acute myeloid leukemia. Oncol Rep 2007, 18:1395-1402.
3. Verhaak R.G., Valk P.J. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia. Cancer Treat Res 2009, 145:67-83.
4. Danen-van Oorschot A.A., Kuipers J.E., Arentsen-Peters S., Schotte D., de Haas V., Trka J., et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer 2012, 58:715-721.
5. Liu X., Liu L., Xu Q., Wu P., Zuo X., Ji A. MicroRNA as a novel drug target for cancer therapy. Expert Opin Biol Ther 2012, 12:573-580.
6. Esteller M. Non coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
7. van Kouwenhove M., Kedde M., Agami R. MicroRNA regulation by RNA binding proteins and its implications for cancer. Nat Rev Cancer 2011, 11:644-656.
8. Dela Cruz F., Matushansky I. MicroRNAs in chromosomal translocation associated solid tumors: learning from sarcomas. Discov Med 2011, 12:307-317.
9. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102:13944-13949.
10. Lopotová T., Záčková M., Klamová H., Moravcová J. MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?. Leuk Res 2011, 35:974-977.
11. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
12. Chen K.C., Liao Y.C., Hsieh I.C., Wang Y.S., Hu C.Y., Juo S.H. OxLDL causes both epigenetic modification and signaling regulation on the microRNA-29b gene: novel mechanisms for cardiovascular diseases. J Mol Cell Cardiol 2012, 52:587-595.
13. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007, 104:15805-15810.
14. Weissmann-Brenner A., Kushnir M., Lithwick Yanai G., Aharonov R., Gibori H., Purim O., et al. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer. Int J Oncol 2012, 40:2097-2103.
15. Pekarsky Y., Santanam U., Cimmino A., Palamarchuk A., Efanov A., Maximov V., et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006, 66:11590-11593.
16. Ma W., Xie S., Ni M., Huang X., Hu S., Liu Q., et al. MicroRNA-29a inhibited epididymal epithelial cell proliferation by targeting nuclear autoantigenic sperm protein (NASP). J Biol Chem 2012, 287:10189-10199.
17. Kong G., Zhang J., Zhang S., Shan C., Ye L., Zhang X. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011, 6:e19518.
18. Han Y.C., Park C.Y., Bhagat G., Zhang J., Wang Y., Fan J.B., et al. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 2010, 207:475-489.
19. Wang X.S., Gong J.N., Yu J., Wang F., Zhang X.H., Yin X.L., et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 2012, 119:4992-5004.
20. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
21. Schwind S., Marcucci G., Maharry K., Radmacher M.D. CALGB. MicroRNA 181a expression as a prognosticator in cytogenetically normal acute myeloid leukemia. J Clin Oncol 2009, 27:15s.
22. Forrest A.R., Kanamori-Katayama M., Tomaru Y., Lassmann T., Ninomiya N., Takahashi Y., et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010, 24:460-466.
23. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
24. Li Y., Kong D., Ahmad A., Bao B., Dyson G., Sarkar F.H. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics 2012, 7:940-949.